Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.
Ferrari SM, Patrizio A, Mazzi V, Ragusa F, Botrini C, Elia G, Balestri E, Barozzi E, Rugani L, Bracchitta F, Stoppini G, Frenzilli G, Baldini E, Virili C, Benvenga S, Fallahi P, Antonelli A. Ferrari SM, et al. Among authors: baldini e. Front Endocrinol (Lausanne). 2024 Apr 11;15:1386510. doi: 10.3389/fendo.2024.1386510. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38665263 Free PMC article. Review.
Sorafenib in the treatment of thyroid cancer.
Ferrari SM, Politti U, Spisni R, Materazzi G, Baldini E, Ulisse S, Miccoli P, Antonelli A, Fallahi P. Ferrari SM, et al. Among authors: baldini e. Expert Rev Anticancer Ther. 2015;15(8):863-74. doi: 10.1586/14737140.2015.1064770. Epub 2015 Jul 7. Expert Rev Anticancer Ther. 2015. PMID: 26152651
Molecular Targeted Therapies of Aggressive Thyroid Cancer.
Ferrari SM, Fallahi P, Politti U, Materazzi G, Baldini E, Ulisse S, Miccoli P, Antonelli A. Ferrari SM, et al. Among authors: baldini e. Front Endocrinol (Lausanne). 2015 Nov 20;6:176. doi: 10.3389/fendo.2015.00176. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 26635725 Free PMC article. Review.
Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells.
Baldini E, Tuccilli C, Prinzi N, Sorrenti S, Antonelli A, Fallahi P, Mian C, Barollo S, Catania A, Morrone S, Tartaglia F, Mascagni D, Coccaro C, Pepe M, Filippini A, D'Armiento M, Ulisse S. Baldini E, et al. J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):793-803. J Biol Regul Homeost Agents. 2015. PMID: 26753639
Deregulated expression of VHL mRNA variants in papillary thyroid cancer.
Baldini E, Tuccilli C, Arlot-Bonnemains Y, Chesnel F, Sorrenti S, De Vito C, Catania A, D'Armiento E, Antonelli A, Fallahi P, Watutantrige-Fernando S, Tartaglia F, Barollo S, Mian C, Bononi M, Arceri S, Mascagni D, Vergine M, Pironi D, Monti M, Filippini A, Ulisse S. Baldini E, et al. Mol Cell Endocrinol. 2017 Mar 5;443:121-127. doi: 10.1016/j.mce.2017.01.019. Epub 2017 Jan 12. Mol Cell Endocrinol. 2017. PMID: 28089820 Free article.
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer.
Tuccilli C, Baldini E, Arlot-Bonnemains Y, Chesnel F, Sorrenti S, De Vito C, D'Armiento E, Antonelli A, Fallahi P, Watutantrige S, Tartaglia F, Barollo S, Mian C, Arcieri S, Mascagni D, Pironi D, Bononi M, Vergine M, Monti M, Filippini A, Ulisse S. Tuccilli C, et al. Among authors: baldini e. Int J Oncol. 2017 Apr;50(4):1413-1422. doi: 10.3892/ijo.2017.3907. Epub 2017 Mar 8. Int J Oncol. 2017. PMID: 28350047
CCL2 is Modulated by Cytokines and PPAR-γ in Anaplastic Thyroid Cancer.
Ferrari SM, Elia G, Piaggi S, Baldini E, Ulisse S, Miccoli M, Materazzi G, Antonelli A, Fallahi P. Ferrari SM, et al. Among authors: baldini e. Anticancer Agents Med Chem. 2018;18(3):458-466. doi: 10.2174/1871520617666170719152349. Anticancer Agents Med Chem. 2018. PMID: 28730964
532 results